Promising COVID-19 rapid test technology enters phase 1 of NIH challenge

(Columbia University School of Engineering and Applied Science) A promising new COVID-19 rapid-testing technology platform developed by Rover Diagnostics and Columbia Engineering has been selected by the NIH to enter Phase 1 of the RADx initiative to support new COVID-19 testing technologies. The affordable, portable, and ultrafast point-of-care Rover platform provides reverse transcription polymerase chain reaction results in eight minutes, faster than any other test of its kind, with targeted accuracy to match laboratory-based tests.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news